Allergy Therapeutics Statistics
Total Valuation
AGYTF has a market cap or net worth of 878.42 million. The enterprise value is 942.86 million.
| Market Cap | 878.42M |
| Enterprise Value | 942.86M |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 4.77B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +27.33% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | 3.39% |
| Float | 325.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.65 |
| PB Ratio | -22.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.15 |
| EV / Sales | 12.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -21.94 |
Financial Position
The company has a current ratio of 1.28
| Current Ratio | 1.28 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.92 |
| Interest Coverage | -4.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.58% |
| Return on Invested Capital (ROIC) | -149.09% |
| Return on Capital Employed (ROCE) | -70.59% |
| Weighted Average Cost of Capital (WACC) | 8.88% |
| Revenue Per Employee | 129,132 |
| Profits Per Employee | -94,149 |
| Employee Count | 584 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 1.93 |
Taxes
In the past 12 months, AGYTF has paid 1.28 million in taxes.
| Income Tax | 1.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +83.33% in the last 52 weeks. The beta is 0.85, so AGYTF's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +83.33% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.31 |
| Average Volume (20 Days) | 13,697 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AGYTF had revenue of 75.41 million and -54.98 million in losses. Loss per share was -0.01.
| Revenue | 75.41M |
| Gross Profit | 40.15M |
| Operating Income | -39.03M |
| Pretax Income | -53.71M |
| Net Income | -54.98M |
| EBITDA | -35.86M |
| EBIT | -39.03M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 17.52 million in cash and 82.32 million in debt, with a net cash position of -64.80 million.
| Cash & Cash Equivalents | 17.52M |
| Total Debt | 82.32M |
| Net Cash | -64.80M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -38.63M |
| Book Value Per Share | -0.01 |
| Working Capital | 10.25M |
Cash Flow
In the last 12 months, operating cash flow was -38.51 million and capital expenditures -4.47 million, giving a free cash flow of -42.98 million.
| Operating Cash Flow | -38.51M |
| Capital Expenditures | -4.47M |
| Free Cash Flow | -42.98M |
| FCF Per Share | n/a |
Margins
Gross margin is 53.23%, with operating and profit margins of -51.75% and -72.91%.
| Gross Margin | 53.23% |
| Operating Margin | -51.75% |
| Pretax Margin | -71.22% |
| Profit Margin | -72.91% |
| EBITDA Margin | -47.56% |
| EBIT Margin | -51.75% |
| FCF Margin | n/a |
Dividends & Yields
AGYTF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.33% |
| Shareholder Yield | -27.33% |
| Earnings Yield | -6.26% |
| FCF Yield | -4.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AGYTF has an Altman Z-Score of -3.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.55 |
| Piotroski F-Score | 2 |